In this article, Michael J. Bloch, MD, writes about orthostatic hypotension (OH), which is a frequent problem in patients with hypertension, including the approach to diagnosis and management of patients...
In this commentary, Michael J Bloch, MD, writes about the use of acetaminophen for pain control in patients with hypertension and patients with an increased risk of cardiovascular events, including results...
In this commentary, Michael J. Bloch, MD, and Evan Bloch discuss the optimal approach to managing patients with hypertension in the United States, including using patients' self-measured blood pressure and...
In this article, Michael J Bloch, MD, discusses the usage of RAS-blocking agents, slowing the progression of end-stage renal disease, and reducing cardiovascular events in patients with advanced kidney...
In this article, Michael Bloch, MD, and Evan Bloch discuss findings from the SELECT trial, including the use of the glucagon-like peptide 1 receptor agonist, semaglutide, to reduce the risk of major...
In this article, Michael J. Bloch, MD, writes about the results of the recently published BrightHTN study, which examined the use of the investigational aldosterone synthase inhibitor baxdrostat in patients...
In this article, Michael J. Bloch, MD, and Evan Bloch discuss the findings from the CARDIA-SSBP trial, which investigates the blood pressure responses to dietary sodium increase and decrease across a wide...
In this commentary, Michael J. Bloch, MD, writes about the risks and benefits of treating patients with mild to moderate hypertension during pregnancy and whether targeting blood pressure of less than...
In this commentary, Michael J. Bloch, MD writes about controversies in the effect of dietary cholesterol and egg consumption on cardiovascular events and mortality.
In this commentary, Michael Bloch, MD, writes about using time in therapeutic range (TTR) to determine dose, dietary recommendations, and a possible need to change anticoagulants for patients on warfarin.
...
